MAPK15 is associated with lymph node metastasis and stimulates lung adenocarcinoma cell movement through prostaglandin E2 receptor and NF-κB p50 signaling [29]. Here, NFKB1 is linked to metastatic malignant neoplasm in the lymph nodes.